These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20154376)

  • 1. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
    Chakraborty SP; Sahu SK; Mahapatra SK; Santra S; Bal M; Roy S; Pramanik P
    Nanotechnology; 2010 Mar; 21(10):105103. PubMed ID: 20154376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus.
    Chakraborty SP; Sahu SK; Pramanik P; Roy S
    Int J Pharm; 2012 Oct; 436(1-2):659-76. PubMed ID: 22841851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
    Whitener CJ; Park SY; Browne FA; Parent LJ; Julian K; Bozdogan B; Appelbaum PC; Chaitram J; Weigel LM; Jernigan J; McDougal LK; Tenover FC; Fridkin SK
    Clin Infect Dis; 2004 Apr; 38(8):1049-55. PubMed ID: 15095205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
    Hiramatsu K
    Lancet Infect Dis; 2001 Oct; 1(3):147-55. PubMed ID: 11871491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S; Nakamachi Y
    Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus.
    Inoue M; Suzuki T; Fujita Y; Oda M; Matsumoto N; Yamase T
    J Inorg Biochem; 2006 Jul; 100(7):1225-33. PubMed ID: 16563513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of Staphylococcus aureus in lymphocytes induces oxidative stress and DNA fragmentation: possible ameliorative role of nanoconjugated vancomycin.
    Chakraborty SP; Kar Mahapatra S; Sahu SK; Das S; Tripathy S; Dash S; Pramanik P; Roy S
    Oxid Med Cell Longev; 2011; 2011():942123. PubMed ID: 21941607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran.
    Aligholi M; Emaneini M; Jabalameli F; Shahsavan S; Dabiri H; Sedaght H
    Med Princ Pract; 2008; 17(5):432-4. PubMed ID: 18685289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Arch Pharm Res; 2008 Jun; 31(6):698-704. PubMed ID: 18563350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.